Esperion Therap (ESPR) Posts Q1 Loss of 51c/Share

Esperion Therap (NASDAQ: ESPR) reported Q1 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Esperion Therap (ESPR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• UBS Upgrades Allegiant Travel Company (ALGT) to Buy, 'Sell-Off Has Created a Compelling Opportunity'
• Oracle’s Ellison cancels plan to sell up to 50 mln shares